Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1983 October; 76(10): 833–840.
PMCID: PMC1439627

Clinical and in vivo response following surgery or surgery plus adjuvant chemotherapy or immunotherapy for colorectal carcinoma in a rat model.


Two cohorts of rats, 240 with colon cancer and 150 controls, were assessed clinically and immunologically for their response to tumour and its management which was either by surgical excision alone or by surgical excision combined with either adjuvant chemotherapy or immunotherapy. The histology and invasion characteristics were observed for similarity with those of human lesions. Metastases were found in liver, lymph nodes, the peritoneum or lungs in 27% of animals during follow up. Significantly fewer adjuvant-treated rats had metastases than those receiving surgery alone (P less than 0.05), and less total tumour weight was found in the adjuvant-treated rats at four (P less than 0.03) and six (P less than 0.001) weeks postoperatively. Animals in the adjuvant immunotherapy group survived longer than in either other group (P less than 0.001). The crude parameters of host response to tumour, body, spleen and mesenteric lymph node weight were recorded and the latter two indexed to body weight. The body weight of tumour and control rats increased significantly with time (P less than 0.04). The spleen and mesenteric node indices were significantly (P less than 0.04) greater in tumour than control rats and were varied by recurrent tumour growth and by the adjuvant treatment administered postoperatively.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (979K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Argyris BF. Suppressor factor from tumor-allosensitized spleen cells--its effect on in vitro proliferation of tumor cells and in vivo skin allograft survival. Cell Immunol. 1981 Jan 1;57(1):62–72. [PubMed]
  • Bansal BR, Mark R, Mobini J, Rhoads JE, Jr, Bansal SC. Demonstration of effective antitumor immunity in an autochthonous host bearing primary colon tumors induced by 1,2-dimethylhydrazine dihydrochloride. J Natl Cancer Inst. 1979 Jul;63(1):127–132. [PubMed]
  • Bansal BR, Mobini J, Bansal SC. Multimodal immunotherapy of primary gastrointestinal tumors in rats. 1. Histologic correlation. Cancer. 1978 Nov;42(5):2079–2096. [PubMed]
  • Bansal SC, Bansal BR, Mark R, Rhoads JE., Jr Effect of unblocking therapy and levamisole on primary gastrointestinal tumors in rats: immunologic and histologic correlation. J Natl Cancer Inst. 1978 Nov;61(5):1235–1254. [PubMed]
  • Bartlett GL, Kreider JW, Purnell DM. Immunotherapy of cancer in animals: models or muddles? J Natl Cancer Inst. 1976 Feb;56(2):207–210. [PubMed]
  • Bruley-Rosset M, Florentin I, Kiger N, Schulz JI, Mathé G. Correction of immunodeficiency in aged mice by levamisole and bestatin administration. Recent Results Cancer Res. 1980;75:139–146. [PubMed]
  • Carachi R, Busuttil A, Joffe SN, Blumgart LH. Multiple polyps and colonic neoplasia induced in the rat. J Surg Res. 1980 Oct;29(4):363–370. [PubMed]
  • Chapuis PH, Newland RC, Payne JE, Macpherson JG, Pheils MT. Preoiperative carcinoembryonic antigen level and prognosis in colorectal cancer. Med J Aust. 1980 Aug 9;2(3):140–143. [PubMed]
  • Cutler SJ, Myers MH, Green SB. Trends in survival rates of patients with cancer. N Engl J Med. 1975 Jul 17;293(3):122–124. [PubMed]
  • Davis S, Mietlowski W, Rohwedder JJ, Griffin JP, Neshat AA. Levamisole as an adjuvant to chemotherapy in extensive bronchogenic carcinoma: a Veterans Administration Lung Cancer Group Study. Cancer. 1982 Aug 15;50(4):646–651. [PubMed]
  • Edwards AJ. Lymphocyte depression by cancer. Ann R Coll Surg Engl. 1977 May;59(3):222–230. [PMC free article] [PubMed]
  • Faulkner KW, House AK. Comparative survival rates in symptomatic peripheral vascular disease and colorectal cancer. Aust N Z J Surg. 1981 Apr;51(2):152–156. [PubMed]
  • Futrell JW, Myers GH. Role of regional lymphatics in tumor allograft rejection. Transplantation. 1972 Jun;13(6):551–557. [PubMed]
  • Grage TB, Moss SE. Adjuvant chemotherapy in cancer of the colon and rectum: demonstration of effectiveness of prolonged 5-FU chemotherapy in a prospectively controlled, randomized trial. Surg Clin North Am. 1981 Dec;61(6):1321–1329. [PubMed]
  • Gray BN. Colorectal cancer: the modern treatment of disseminated disease - a review. Aust N Z J Surg. 1980 Dec;50(6):647–658. [PubMed]
  • House AK. The immune response to carcinoma of the colon in a rat model: a temporal study. Aust N Z J Surg. 1981 Oct;51(5):487–493. [PubMed]
  • Jessup JM, Kahan BD, Pellis NR. Mechanisms of immunosuppression in tumor-bearing mice: a multifactorial analysis. Cancer. 1982 Mar 15;49(6):1158–1167. [PubMed]
  • Jones JA, Robinson G, Rees RC, Baldwin RW. Immune response of the draining and distal lymph nodes during the progressive grwoth of a chemically-induced transplantable rat hepatoma. Int J Cancer. 1978 Feb 15;21(2):171–178. [PubMed]
  • Lavin P, Mittelman A, Douglass H, Jr, Engstrom P, Klaassen D. Survival and response to chemotherapy for advanced colorectal adenocarcinoma: an Eastern Cooperative Oncology Group report. Cancer. 1980 Oct 1;46(7):1536–1543. [PubMed]
  • McDermott FT, Hughes ES, Pihl E, Price AB. Changing survival prospects in rectal and colonic cancer. Aust N Z J Surg. 1981 Apr;51(2):120–127. [PubMed]
  • Meyer JD, Argyris BF, Meyer JA. Splenectomy, suppressor cell activity, and survival in tumor bearing rats. J Surg Res. 1980 Dec;29(6):527–532. [PubMed]
  • Mitchell MS, DeConti RC. Immunosuppression by 5-fluorouracil. Cancer. 1970 Oct;26(4):884–889. [PubMed]
  • Mitcheson HD, Sadler TE, Castro JE. Single versus multiple human-equivalent doses of C. parvum in mice: neutralization of the anti-metastatic effect. Br J Cancer. 1980 Mar;41(3):407–414. [PMC free article] [PubMed]
  • Moertel CG, Ritts RE, Jr, Schutt AJ, Hahn RG. Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer. Cancer Res. 1975 Nov;35(11 Pt 1):3075–3083. [PubMed]
  • Narisawa T, Kohno KI, Yamaguchi T, Takahashi T. Chemoprevention of development of colonic adenomatosis and carcinomatosis with intrarectal dose of 5-FU on animal model. Cancer. 1980 Feb;45(3):439–443. [PubMed]
  • Nigro ND, Bhadrachari N, Chomchai C. A rat model for studying colonic cancer: effect of cholestyramine on induced tumors. Dis Colon Rectum. 1973 Nov-Dec;16(6):438–443. [PubMed]
  • Pavlovsky S, Muriel FS, Garay G, Svarch E, Braier J, Lagarde M, Scaglione C, Eppinger-Helft M, Failace R, Dibar E. Chemoimmunotherapy with levamisole in acute lymphoblastic leukemia. Cancer. 1981 Oct 1;48(7):1500–1507. [PubMed]
  • Payne JE, Pheils MT, Chapuis PH, MacPherson JG. The effect of fluorouracil on survival in metastatic colorectal cancer fluorouracil response improves survival. Aust N Z J Surg. 1981 Feb;51(1):12–16. [PubMed]
  • Pozharisski KM. Morphology and morphogenesis of experimental epithelial tumors of the intestine. J Natl Cancer Inst. 1975 May;54(5):1115–1135. [PubMed]
  • Radley JM, Hodgson GS, Thean LE, Zangheri O, Levin J. Increased megakaryocytes in the spleen during rebound thrombocytosis following 5-fluorouracil. Exp Hematol. 1980 Oct;8(9):1129–1138. [PubMed]
  • Steele G, Jr, Harte PJ, Rayner AA, Corson JM, Madara J, Munroe AE, King VP, Wilson RE. The effect of adjuvant immunotherapy on tumor recurrence after segmental resection of carcinogen-induced Wistar/Furth primary bowel adenocarcinomas. J Immunol. 1982 Jan;128(1):7–10. [PubMed]
  • Taylor I, Rowling J, West C. Adjuvant cytotoxic liver perfusion for colorectal cancer. Br J Surg. 1979 Dec;66(12):833–837. [PubMed]
  • Turnbull RB., Jr Current concepts in cancer. Cancer of the GI tract: colon, rectum, anus. The no-touch isolation technique of resection. JAMA. 1975 Mar 17;231(11):1181–1182. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press